Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.
CBI provides integrated solutions to global health
CBI Activities
Collaboration
MIT CBI is home to the Biomanufacturing Consortium (BioMAN), and the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB). These pre-competitive programs provide a safe haven where industry, academia, and government collaboratively address challenges in manufacturing, delivery, and access to biologics through focused events and projects that address key challenges in biomanufacturing.
Education
MIT CBI has developed a number of biomanufacturing-related educational offerings including a residential MIT course, an on-line course on the principles of manufacturing protein and antibody drugs, and a short course on vaccine manufacturing offered jointly with University College London. We have developed a blended learning course for the training of cell therapy manufacturing personnel which will combine online learning with hands-on training.
Research
MIT CBI research projects focus on biomanufacturing process innovation for production of biologic medicines including monoclonal antibodies, vaccines, viral vectors, and cell therapies. Our main research areas include process analytical technologies, biomanufacturing data analytics, advanced process modeling and control, and continuous manufacturing.
Upcoming Events
2025 Vaccines Bioprocess Development & Commercialization Workshop
100 Main St, Building E62-250, Cambridge, MA, 100 Main St, Building E62-250, Cambridge, MA 02139
2025 BioMAN Workshop
Samberg Conference Center, 50 Memorial Drive, Cambridge MA
Latest News & Research
-
BioACCESS contributes to the IAVI Wellcome report on expanding global access to mAb-based products.
BioACCESS took part in consultations and reviewed the IAVI Welcome report, which sets out a roadmap to make lifesaving…
-
BioPharm International publishes CBI Article on the Impact of SARS-CoV-2 on Biomanufacturing Operations
CBI has published a summary of the key takeaways from “The Impact of SARS-CoV-2 on Biomanufacturing Operations”, the first…
-
NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing, July 20th, 2020
On behalf of the NEWDIGS initiative / FoCUS Project, team members submitted comments on the recent CMS Proposed Rule supporting Value-Based Purchasing…
Our Members
Our members and collaborators are leading stakeholders across the global healthcare value chain, from R&D and manufacturing to delivery and reimbursement.
